13D Filing: VenBio Select Advisor and Immunomedics Inc (IMMU)

Page 5 of 6 – SEC Filing

Item 7. EXHIBITS
 
Item 7 of the Schedule 13D is hereby amended and supplemented by the addition of the following:
 
Exhibit Description
   
2 Securities Purchase Agreement, dated as of May 4, 2017  (incorporated by reference to an exhibit to the Issuer’s Current Report on Form 8-K, anticipated to be filed by the Issuer with the SEC on or around May 10, 2017.)

Follow Immunomedics Inc (NASDAQ:IMMU)